Alpha Genesis, Inc. (AGI) is a leading provider of preclinical research services, specializing in nonhuman primate (NHP) models that advance the development of safe and effective therapies. With decades of experience and the largest purpose-bred primate colonies in the United States, we deliver reliable, translational solutions that drive research from discovery through regulatory submission.

 

Our mission is to accelerate breakthroughs in human and animal health by combining world-class animal care, state-of-the-art facilities, and a team of experienced scientists, veterinarians, and technicians. AGI recognizes that great science depends on great stewardship, and we uphold the highest standards of animal welfare, biosecurity, and regulatory compliance to ensure our operations are conducted with integrity and precision.

 

AGI offers comprehensive capabilities tailored to client needs, from pharmacology and toxicology to surgical models, imaging, and regulatory support. Our programs span exploratory research through IND-enabling studies, with services designed to de-risk candidate therapies and provide clear, reproducible outcomes. By integrating advanced imaging, molecular analytics, and specialized model development, we help sponsors generate the data needed to move promising therapies into the clinic.

 

At AGI, we are collaborators dedicated to improving health worldwide. Every study, every animal, and every data point reflects our commitment to ethical scientific advancement.